Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes

Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes

Abstract Background Diabetes mellitus is a risk for increased incidence of adverse clinical events after percutaneous coronary intervention. However, the difference in the incidence of adverse clinical events according to stent type in patients with diabetes remains to be elucidated. In the present...

Full description

Bibliographic Details
Main Authors: Ryota Kakizaki, Yoshiyasu Minami, Masahiro Katamine, Aritomo Katsura, Yusuke Muramatsu, Takuya Hashimoto, Kentaro Meguro, Takao Shimohama, Junya Ako
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Cardiovascular Diabetology
Subjects:
Drug-eluting stent
Percutaneous coronary intervention
Target lesion revascularization
Online Access:http://link.springer.com/article/10.1186/s12933-020-01145-x

Internet

http://link.springer.com/article/10.1186/s12933-020-01145-x

Similar Items